Pathogenesis and Treatment of HIV Infection
$2,719,569Z01FY2007AINIH
Niaid Extramural Activities
Investigators
Linked publications & trials
Paper 19617815Paper 18493981Paper 18456875Paper 18448620Paper 18090390Paper 17674308Paper 17670817Paper 17596352Paper 17576678Paper 17395779Paper 17093193Paper 17068156Paper 17003402Paper 16871325Paper 16837861Paper 16731952Paper 16544259Paper 16439869Paper 16280692Paper 16136473Paper 15937547Paper 15643013Paper 15090457Paper 14645561Paper 14640722Paper 14600575Paper 14519205Paper 12794543Paper 12734009Paper 12502817Paper 12496379Paper 12370415Paper 12230939Paper 12149467Paper 11748275Paper 11579237Paper 11465092Paper 11264389Paper 11118073Paper 11106537Paper 11095734Paper 10985306Paper 10915073Paper 10623768
Abstract
IL-27 was identified as a cytokine with anti-HIV properties acting via similar although distinct pathways from those used by interferon-alpha. Cessation of antiretroviral therapy was found to diminish but not completely suppress the increases in CD4 T cells that are seen with IL-2. This finding was complemented by the discoveries that the increases in CD4 counts seen with IL-2 are correlated with changes in the state of baseline activation and that one can see increases in CD4 counts with IL-2 in patients who have never received antiretrovirals.
View original record on NIH RePORTER →